© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Increased aortic blood pressure contributes to potentiated dobutamine inotropic responses after systemic NO synthase inhibition in sheep
aInstitute of Reproduction and Development, Monash University, Clayton, Victoria, Australia
bCentre for Heart and Chest Research, Monash University, Clayton, Victoria, Australia
cDepartment of Cardiology, Royal Children's Hospital, Melbourne, Australia
* Corresponding author. Tel.: +61-3-9550-5470; Fax: +61-3-9550-5554; E-mail: joe.smolich@med.monash.edu.au
Objective: To determine whether inotropic responses to the β-adrenergic agonist dobutamine are potentiated by systemic inhibition of nitric oxide synthase (NOS) with the L-arginine analogue N
-nitro-L-arginine (L-NNA), and to establish to what extent any observed responses are related to the increase in aortic blood pressure accompanying systemic NOS inhibition. Methods: Dobutamine was infused incrementally at rates of 1, 2.5, 5 and 10 µg/kg/min in 15 open-chest, anaesthetised ewes before and after inhibition of NO synthesis with i.v. L-NNA (n=8), or elevation of mean aortic blood pressure to the same extent as attained with NOS inhibition using proximal arterial occlusion (n=7). Results: By the peak infusion rate, dobutamine increased the maximal rate of rise of left ventricular pressure (LV dP/dtMAX) by 100% (p<0.001) and reduced LV stroke work by 18% (p<0.01). L-NNA and arterial occlusion increased resting mean aortic blood pressure by 55±4 and 51±3 mmHg respectively. Compared to dobutamine alone, subsequent peak dobutamine-related increases in LV dP/dtMAX were augmented by 76% after L-NNA and by 88% after arterial occlusion (both p<0.001). Moreover, dobutamine increased LV stroke work by 23% at infusion rates of 1–5 µg/kg/min (p<0.001) after L-NNA, and by 17% at an infusion rate of 1 µg/kg/min (p<0.01) after arterial occlusion. Conclusions: Systemic NOS inhibition potentiates the effects of dobutamine on LV isovolumic and pumping performance in the intact circulation, but this potentiation is in large part related to the increase in arterial blood pressure accompanying NOS inhibition.
KEYWORDS Nitric oxide; Ventricular function; Inotropic agents; Adrenergic agents; Blood pressure
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Penny, J. P. Mynard, and J. J. Smolich Aortic wave intensity analysis of ventricular-vascular interaction during incremental dobutamine infusion in adult sheep Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H481 - H489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. J. Leeuwenburgh, W. A. Helbing, P. Steendijk, P. H. Schoof, and J. Baan Biventricular systolic function in young lambs subject to chronic systemic right ventricular pressure overload Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2697 - H2704. [Abstract] [Full Text] [PDF]
|
|